Neurotoxicity-induced changes in striatal dopamine receptor function

Annals of the New York Academy of Sciences

Volumn 991, Issue , 2003, Pages 281-283

  Brownell, Anna Liisa ^a   Chen, Iris Y ^a   Wang, Xukui ^a   Yu, Meixiang ^a   Jenkins, Bruce G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Dopamine receptor; Dopamine transporter; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN INJURY; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUNTINGTON CHOREA; MALE; NEUROTOXICITY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; RECEPTOR BINDING;

ANIMALIA;

EID: 0038389515     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07484.x     Document Type: Conference Paper

References (7)

1. ANDREWS, T.C., et al. 1998. Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPECT. Mol. Med. Today 4(12): 532-539.
2. ANDREWS, T.C., et al. 1999. Huntington's disease progression, PET and clinical observations. Brain 122(Pt. 12): 2353-2363.
3. ALSTON, T.A., et al. 1977. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc. Natl. Acad. Sci. USA 74: 3767-3771.
4. BROWNELL, G.L., et al. 1985. High resolution tomograph using analog coding. In The Metabolism of the Human Brain. Studies with Positron Emssion Tomography. T. Greitz et al., Eds.: 13-19. Raven Press. New York.
5. ARAUJO, M.D. et al. 2000. Deficits in striatal dopamine D2 receptors and energy metabolism detected by in vivo mirco PET imaging in a rat model of Huntington's disease. Exp. Neurol. 166: 287-297.
6. SUZUKI, M. et al. 2001. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Synapse 41(4): 329-336.
7. GINOVART, N. et al. 1997. PET study of pre- and post-synaptic dopaminergic markers for neurodegenerative process in Huntington's disease. Brain 120: 503-514.